MapLight Therapeutics, Inc. Common Stock (MPLT)
PHARMACEUTICAL PREPARATIONS
MapLight Therapeutics, Inc. Common Stock (MPLT) is listed on Nasdaq, where it has traded since October 27, 2025.
- Listed On
- Nasdaq
- Listed Since
- October 27, 2025
- Employees
- 133
- Market Cap
- $443M
About MapLight Therapeutics, Inc. Common Stock
MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. Its discovery platform identifies neural circuits causally linked to disease and targets them for therapeutic modulation, aiming to improve efficacy, safety, tolerability, and ease of use. The company was founded by leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies. Its product candidate, ML-007C-MA, is a fixed-dose combination of an M1/M4 muscarinic agonist and a peripherally acting anticholinergic, being developed for schizophrenia and Alzheimer's disease psychosis, designed to activate central receptors while mitigating peripheral side effects.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 103 institutions reported holding MPLT, with 26.3 million shares worth $941.0 million in aggregate. The largest reported holder was T. Rowe Price, with 4.2 million shares worth $150.7 million. Of the 5 largest holders listed below, 1 added shares, 2 reduced their positions and 2 held their positions unchanged during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| T. Rowe Price | 4,204,663 | $151M | Added 44.26% |
| Novo Holdings a/S | 3,686,622 | $132M | Unchanged |
| Fcpm III Services B.V | 3,226,400 | $116M | Unchanged |
| Goldman Sachs | 1,948,312 | $70M | Reduced 2.33% |
| BlackRock | 1,025,134 | $37M | Reduced 23.48% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is MPLT?
MapLight Therapeutics, Inc. Common Stock (MPLT) is listed on Nasdaq, where it has traded since October 27, 2025.
Who are the largest institutional holders of MPLT?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of MPLT were T. Rowe Price, Novo Holdings a/S and Fcpm III Services B.V.
How many institutions own MPLT?
103 institutions reported a position in MPLT for the quarter ended June 30, 2026, worth $941.0 million in total.
Did institutions buy or sell MPLT last quarter?
Of the 5 largest reported holders, 1 added shares, 2 reduced their positions and 2 held their positions unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for MPLT.
Every reported institutional holder, plus insider and congressional trades in MPLT, on SentiSense.